AC-SDKP: dosing and reconstitution
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
AC-SDKP (goralatide) is a tetrapeptide administered subcutaneously in studies. The figures below are a generalized reference extrapolated from preclinical (animal) work, not an established human protocol.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 200–500 mcg per day, subcutaneous | Starting dose |
| Main regimen | 0.5–1 mg per day, subcutaneous | Increase if needed |
| Upper reference | up to ~2 mg per day | Maximum in this schedule |